-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Collegium Pharmaceutical, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2023.
- Collegium Pharmaceutical, Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $19.6M, a 50.7% increase year-over-year.
- Collegium Pharmaceutical, Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $99.9M.
- Collegium Pharmaceutical, Inc annual Net Income (Loss) Attributable to Parent for 2023 was $48.2M.
- Collegium Pharmaceutical, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$25M, a 135% decline from 2021.
- Collegium Pharmaceutical, Inc annual Net Income (Loss) Attributable to Parent for 2021 was $71.5M, a 167% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)